Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study)

INTRODUCTION: Preference for quality of life is important in deciding the treatment strategy for patients with type 2 diabetes mellitus. This study aimed to assess the effect of omarigliptin on patients’ psychological attitudes and responses compared with daily dipeptidyl peptidase-4 inhibitors (DPP...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Hitoshi, Kamei, Nozomu, Shimono, Dai, Niiya, Tetsuji, Tosaki, Takahiro, Kitazawa, Toru, Suzuki, Daisuke, Wakasa, Yutaka, Seino, Hiroaki, Oishi, Mariko, Ohashi, Hiroshi, Higami, Kenshi, Akai, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499707/
https://www.ncbi.nlm.nih.gov/pubmed/37468684
http://dx.doi.org/10.1007/s13300-023-01442-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499707/
https://www.ncbi.nlm.nih.gov/pubmed/37468684
http://dx.doi.org/10.1007/s13300-023-01442-0

Ejemplares similares